SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: pull_da_trigger who wrote (724)11/7/2001 9:17:05 PM
From: pull_da_trigger  Respond to of 2243
 
Actually, I realize that even if the 45 patient, 3 center trial is a large, multi-center trial, the goals of this trial don't fit well with your hypothesis that Reolysin will not be able to help patients live longer.

Survival is not one of the measured endpoints of this trial, so the size and multi-centeredness of this particular trial is a moot point.

Cheers,
P.D.T.



To: pull_da_trigger who wrote (724)11/7/2001 10:15:13 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 2243
 
>> Would a 45 patient phase II prostate trial at three or more clinical sites across Canada count as a large, multi-center trial? <<

No.

You are quoting a man with no publications that I can find (despite a long career at the Alberta Research Council, who appears to have no background in the pharma industry or with the development of drugs, and who, when clinicals for reolysin were projected to start Spring 2000, projected that pivotal trials would be completed and approval would come such that marketing could begin "late 2002, early 2003".

Good luck. You've placed your investment bucks in the hands of rank amateurs. I hope that the experience turns out to be a good one. We can use a cancer cure or two, and this one has fun biology behind it. We heard similar noises, and great claims, from Onyx. So you'll have to excuse the "jade".

I've made my call. If I'm wrong, be sure to hurry back and let me know. Despite what Dr. Thompson says, you won't be back until 2005 at the earliest.

That's the very best "pompous ass" that I can do, hope it's sufficient.

Next time that you show up in a thread and ask for opinions? Be sure to tell us that we're supposed to say "sensational, can't miss". Thanks in advance.

Richard C. Harmon, Ph.D.
Proud BioFreak, NBIX Freak, etc.